Phase I study of two different schedules of bortezomib and pemetrexed in advanced solid tumors with emphasis on non-small cell lung cancer

Research output: Contribution to journalArticle

21 Scopus citations

Fingerprint Dive into the research topics of 'Phase I study of two different schedules of bortezomib and pemetrexed in advanced solid tumors with emphasis on non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences